Matthew Boyle

1 week ago | news.bloomberglaw.com | Lily Meier |Jaewon Kang |Matthew Boyle

The relationship that cost Ashley Buchanan his job as CEO of Kohl’s began roughly 10 years ago. It was described by some as an open secret among colleagues and spanned his earlier, high-profile stints at Walmart and Michaels. On May 1, Kohl’s board fired Buchanan after determining he had directed millions of dollars of business to someone he has had a personal relationship with, without disclosing the relationship — a violation of the company’s ethics policy.

1 week ago | bloomberg.com | Lily Meier |Jaewon Kang |Matthew Boyle

Kohl's alleged on Thursday that Ashley Buchanan pushed the retailer to do business with a vendor "that involved undisclosed conflicts of interest."(Bloomberg) -- The relationship that cost Ashley Buchanan his job as CEO of Kohl’s began roughly 10 years ago. It was described by some as an open secret among colleagues and spanned his earlier, high-profile stints at Walmart and Michaels.

1 week ago | news.bloomberglaw.com | Lily Meier |Matthew Boyle

Kohl’s Corp. fired its chief executive officer only months into his tenure after the board uncovered that he directed millions of dollars of business to someone he has had a romantic relationship with, according to a person familiar with the matter. The company said it’s starting a search to find a permanent CEO replacement following the departure of Ashley Buchanan, who came to Kohl’s in January from retailer Michaels Cos.

1 week ago | bloomberg.com | Lily Meier |Matthew Boyle

A Kohl's store in Pleasant Hill, California, US, on Monday, Nov. 25, 2024. Kohl's Corp. is expected to release earnings figures on November 26. Photographer: David Paul Morris/Bloomberg(Bloomberg) -- Kohl’s Corp. said it fired its chief executive officer only months into his tenure after the board uncovered that he directed millions of dollars of business to someone he has had a personal relationship with that wasn’t disclosed.

2 weeks ago | bloomberglinea.com.br | Matthew Boyle |Daniel Acker

Bloomberg — O CEO da PepsiCo, Ramon Laguarta, está acostumado a ser questionado sobre o impacto dos medicamentos para perda de peso nos negócios de sua empresa de alimentos e bebidas. Mas as perguntas não costumam vir de uma menina de 13 anos. “O que você acha do lançamento dos medicamentos orais GLP-1, que chegarão ao mercado no ano que vem?”, perguntou Milena Gajrawala, filha adolescente do analista Kaumil Gajrawala, da Jefferies.